AUSTIN, Texas, Sept. 12, 2024 /PRNewswire/ — NeuFit is revolutionizing neurological rehabilitation with its innovative approach that integrates advanced diagnostics and therapeutic technologies. At the center of NeuFit’s success is the NEUBIE (Neuro-Bio-Electric Stimulator), a cutting-edge device that utilizes direct current (DC) electrical stimulation to promote accelerated recovery, enhance performance, and improve overall well-being. This press release highlights NeuFit’s unique approach and its multi-site clinical trial collaboration with Hands-On Diagnostics (HODS) to address neuropathy.

Researchers at the University of Pittsburgh are pioneering a new approach to blood pressure monitoring—using the devices we carry with us every day.

“We are adding a new layer of control between the world of computers and what your eyes see,” says Barmak Heshmat, co-founder of Brelyon and a former MIT postdoc.

iRhythm Technologies (Nasdaq: IRTC)+ announced that it received approval in Japan for its Zio long-term continuous monitoring (LTCM) system.

Researchers at the Georgia Institute of Technology have developed a deep learning (DL) model that they paired with a wearable patch equipped with a highly sensitive sensor that can automatically detect wheezing sounds

It is the first magnetically controlled prosthetic hand that allows amputees to reproduce all movements simply by thinking and to control the force applied when grasping fragile objects. No wires, no electrical connection, only magnets and muscles to control the movements of the fingers and enable everyday activities such as opening a jar, using a screwdriver, picking up a coin.

Smith+Nephew (NYSE: SNN)+
announced that it launched its Total Ankle patient-matched, 3D-printed guides for planning and performing replacement procedures.

Hinge Health announced that it launched its Enso 3 FDA-cleared wireless device for reducing musculoskeletal pain.